We measure appointment access time by calculating the number of days between the date a new patient appointment or consultation was scheduled and the date the appointment occurred. The data below shows the median number of calendar days.
We have included every new patient seen in the last six months by a medical oncologist, surgeon, or radiation oncologist at our major practice locations: Dana-Farber Cancer Institute, Brigham and Women's Hospital and Faulkner Hospital. This includes patients who suspect they have cancer and those with a confirmed diagnosis of cancer.
Some patients choose to take the first available appointment, while others prefer to wait for a specific doctor or location, or a more convenient date, especially if they have to arrange travel plans.
Patients with urgent situations are seen immediately by a predefined triaging process.
We have made it a priority to improve appointment availability. Our target appointment access time is a maximum of 14 calendar days, or 10 business days. The treatment centers currently meeting this target are Breast, Gastrointestinal, Gynecologic, Hematologic Malignancies, Neurologic, and Sarcoma.
Once this target is reached, we aim to meet a target of seven calendar days, or five business days; the treatment centers meeting this target are Head and Neck and Thoracic.
We distribute detailed data reports each month and work with treatment center leaders to identify opportunities for improvement unique to their center.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: